NeuroQore, Inc.
PrivateLast Round
Seed
Jul 14, 2025
Est. Valuation
$10.6M
Total Funding Raised
$1.51M
Company Overview
NeuroQore, Inc. operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Seed round in July 2025.
NeuroQore, Inc. is a medtech company developing neuromodulation treatment systems for major depressive disorder and suicidality.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroQore, Inc. Comparables
Compare NeuroQore, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wave Neuroscience | 83% | |
| Magnus Medical | 81% | |
| Sooma | 77% |
For institutional investors. Book with your work email.
NeuroQore, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 14, 2025 | ||||
| Grant | Jun 18, 2020 | ||||
| Accelerator | Aug 2, 2018 |
For institutional investors. Book with your work email.
NeuroQore, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Grant |
| IndieBio | Accelerator |
| SOSV | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2025
$1.51M raised in Seed round.
- Jun 18, 2020
Received funding from Ontario Brain Institute.
For institutional investors. Book with your work email.
NeuroQore, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroQore, Inc.'s valuation, stock price, and market status.
Is NeuroQore, Inc. a public or private company?
NeuroQore, Inc. is a private company.
What is the current stock price of NeuroQore, Inc.?
NeuroQore, Inc. is a private company, so its shares have no public market price. Caplight tracks NeuroQore, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroQore, Inc. worth (valuation)?
NeuroQore, Inc.'s valuation is estimated at $10.6M based on funding round data.
Can I buy NeuroQore, Inc. stock?
NeuroQore, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroQore, Inc.'s last funding round?
NeuroQore, Inc.'s most recent funding round was Seed on July 14, 2025.
Who are the main investors in NeuroQore, Inc.?
Key investors in NeuroQore, Inc. include IndieBio.
Will NeuroQore, Inc. IPO soon?
No public IPO plans have been announced for NeuroQore, Inc..
How can I track NeuroQore, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NeuroQore, Inc.'s shares on secondary markets.